Since the appearance of an ozone hole over the Antarctic in the early 1980s, Americans have become aware of the health threats posed by ozone depletion, which decreases our atmosphere's natural protection from the sun's harmful ultra-violet (UV) rays.(8)
The incidence of skin cancer in the United States has reached epidemic propor-tions. One in five Americans will develop skin cancer in their lifetime, and one American dies every hour from this devastating disease. Medical research is help-ing us understand the causes and effects of skin cancer. Many health and educa-tion groups are working to reduce the incidence of this disease, of which 1.3 million cases have been predicted for 2000 alone, according to The American Cancer Society.
Melanoma, the most serious form of skin cancer, is also one of the fastest growing types of cancer in the United States. Many dermatologists believe there may be a link between childhood sunburns and melanoma later in life. Melanoma cases in this country have more than doubled in the past 2 decades, and the rise is expect-ed to continue.
Nonmelanoma Skin Cancers
Nonmelanoma skin cancers are less deadly than melanomas. Nevertheless, left untreated, they can spread, causing disfigurement and more serious health problems. More than 1.2 million Americans will develop nonmelanoma skin cancer in 2000 while more than 1,900 will die from the disease. There are two primary types of nonmelanoma skin cancers. These two cancers have a cure rate as high as 95 percent if detected and treated early. The key is to watch for signs and seek medical treatment.
Basal Cell Carcinomas are the most common type of skin cancer tumors. They usually appear as small, fleshy bumps or nodules on the head and neck, but can occur on other skin areas. Basal cell carcinoma grows slowly, and rarely spreads to other parts of the body. It can, however, penetrate to the bone and cause considerable damage.
Squamous Cell Carcinomas are tumors that may appear as nodules or as red, scaly patches. This cancer can develop into large masses, and unlike basal cell carcinoma, it can spread to other parts of the body.
Other Skin Damage
Other UV-related skin disorders include actinic keratoses and premature aging of the skin. Actinic keratoses are skin growths that occur on body areas exposed to the sun. The face, hands, forearms, and the "V" of the neck are especially susceptible to this type of lesion. Although premalignant, actinic keratoses are a risk factor for squamous cell carcinoma. Look for raised, reddish, rough-textured growths and seek prompt medical attention if you discover them. Chronic exposure to the sun also causes premature aging, which over time can make the skin become thick, wrinkled, and leathery. Since it occurs gradually, often manifesting itself many years after the majority of a person's sun exposure, premature aging is often regarded as an unavoidable, normal part of growing older. With proper protection from UV radiation, however, most premature aging of the skin can be avoided.
Cataracts and Other Eye Damage
Cataracts are a form of eye damage in which a loss of transparency in the lens of the eye clouds vision. If left untreated, cataracts can lead to blindness. Research has shown that UV radiation increases the likelihood of certain cataracts. Although curable with modern eye surgery, cataracts diminish the eyesight of millions of Americans and cost billions of dollars in medical care each year. Other kinds of eye damage include pterygium (i.e., tissue growth that can block vision), skin cancer around the eyes, and degeneration of the macula (i.e., the part of the retina where visual perception is most acute). All of these problems can be lessened with proper eye protection from UV radiation.
Scientists have found that overexposure to UV radiation may suppress proper functioning of the body's immune system and the skin's natural defenses. All people, regardless of skin color, might be vulnerable to effects including impaired response to immunizations, increased sensitivity to sunlight, and reac-tions to certain medications.